May 13 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Mar 31, 2026 Mar 31, 2025 Jun 30, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.11 1.27 1.42
(-12.6 pct) (+13.5 pct) (-2.4 pct)
Operating 208 mln 353 mln 210 mln
(-41.1 pct) (+40.5 pct) (-15.8 pct)
Recurring 209 mln 342 mln 210 mln
(-38.8 pct) (+36.0 pct) (-12.9 pct)
Net 165 mln 304 mln 200 mln
(-45.6 pct) (+33.2 pct) (-22.0 pct)
EPS 29.35 yen 51.53 yen 35.59 yen
Ann Div 15.00 yen 18.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 18.00 yen
NOTE - Human Metabolome Technologies, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T